Active Ingredients
(in each extended-release tablet)
Dextromethorphan Hydrobromide USP 30 mg
Guaifenesin USP 600 mg
The following Structured Product Label (SPL) was submitted to the FDA by Aurohealth Llc for the product Guaifenesin And Dextromethorphan Hbr (NDC 58602-714). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients, purpose, uses, warnings, ask a doctor before use if you have, when using this product, stop use and ask a doctor if, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
(in each extended-release tablet)
Dextromethorphan Hydrobromide USP 30 mg
Guaifenesin USP 600 mg
Cough suppressant
Expectorant
Do not use
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
colloidal silicon dioxide, hypromellose, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch (maize)
call 1-855-274-4122 You may also report side effects to this phone number.
Compare to the active
ingredients of Mucinex® DM*
NDC 58602-714-05
Mucus Relief DM
Guaifenesin and Dextromethorphan HBr
Extended-release Tablets
600 mg/30 mg
EXPECTORANT AND
COUGH SUPPRESSANT
12 HOUR
Controls Cough
Thins and Loosens Mucus
14 Extended-release Tablets
AUROHEALTH
Compare to the active
ingredients of Mucinex® DM*
NDC 58602-714-67
Mucus Relief DM
Guaifenesin and
Dextromethorphan HBr
Extended-release Tablets
600 mg/30 mg
EXPECTORANT AND
COUGH SUPPRESSANT
12 HOUR
Controls Cough
Thins and Loosens Mucus
20 (2 x 10) Extended-release Tablets
AUROHEALTH
* Please review the disclaimer below.